{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:32:54Z","timestamp":1784129574232,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ecl.2020.10.003","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T16:51:03Z","timestamp":1610556663000},"page":"25-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Polycystic Ovary Syndrome"],"prefix":"10.1016","volume":"50","author":[{"given":"Christine M.","family":"Burt Solorzano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ecl.2020.10.003_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"Clinical practice. Polycystic ovary syndrome","volume":"375","author":"McCartney","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ecl.2020.10.003_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.ecl.2020.10.003_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.ecl.2020.10.003_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000479371","article-title":"An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence","volume":"88","author":"Ibanez","year":"2017","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"10.1016\/j.ecl.2020.10.003_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ecl.2020.10.003_bib6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1210\/endrev\/bnaa010","article-title":"Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome","volume":"41","author":"Stener-Victorin","year":"2020","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.ecl.2020.10.003_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MED.0000000000000445","article-title":"Anti-mullerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome","volume":"25","author":"Dumont","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"6","key":"10.1016\/j.ecl.2020.10.003_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"issue":"10","key":"10.1016\/j.ecl.2020.10.003_bib9","first-page":"1606","article-title":"The genetics of polycystic ovary syndrome: an overview of candidate gene systematic reviews and genome-wide association studies","volume":"8","author":"Hiam","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"12","key":"10.1016\/j.ecl.2020.10.003_bib10","doi-asserted-by":"crossref","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria","volume":"14","author":"Day","year":"2018","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ecl.2020.10.003_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coemr.2020.04.005","article-title":"Central nervous system control in PCOS","volume":"12","author":"McCartney","year":"2020","journal-title":"Curr Opin Endocr Metab Res"},{"key":"10.1016\/j.ecl.2020.10.003_bib12","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-Mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ecl.2020.10.003_bib13","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","article-title":"Elevated prenatal anti-Mullerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood","volume":"24","author":"Tata","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ecl.2020.10.003_bib14","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/en.2014-1887","article-title":"Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization","volume":"156","author":"Caldwell","year":"2015","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.ecl.2020.10.003_bib15","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","article-title":"Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome","volume":"25","author":"Risal","year":"2019","journal-title":"Nat Med"},{"issue":"16","key":"10.1016\/j.ecl.2020.10.003_bib16","doi-asserted-by":"crossref","first-page":"E3334","DOI":"10.1073\/pnas.1616467114","article-title":"Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome","volume":"114","author":"Caldwell","year":"2017","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"8","key":"10.1016\/j.ecl.2020.10.003_bib17","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1210\/jc.2005-2693","article-title":"Increased anti-Mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome","volume":"91","author":"Sir-Petermann","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2020.10.003_bib18","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1210\/jc.2007-0267","article-title":"Anti-Mullerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome","volume":"92","author":"Crisosto","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2020.10.003_bib19","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1210\/jc.2007-1036","article-title":"Early metabolic derangements in daughters of women with polycystic ovary syndrome","volume":"92","author":"Sir-Petermann","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2020.10.003_bib20","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1210\/jc.2008-2836","article-title":"Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome","volume":"94","author":"Sir-Petermann","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2020.10.003_bib21","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1210\/jc.2009-0427","article-title":"Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome","volume":"94","author":"Maliqueo","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2020.10.003_bib22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.fertnstert.2011.10.002","article-title":"Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters","volume":"97","author":"Crisosto","year":"2012","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ecl.2020.10.003_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejogrb.2011.12.012","article-title":"Relationship of serum adipocyte-derived proteins with insulin sensitivity and reproductive features in pre-pubertal and pubertal daughters of polycystic ovary syndrome women","volume":"161","author":"Maliqueo","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.ecl.2020.10.003_bib24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/1933719111424444","article-title":"Relationship between anti-Mullerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome","volume":"19","author":"Sir-Petermann","year":"2012","journal-title":"Reprod Sci"},{"issue":"2","key":"10.1016\/j.ecl.2020.10.003_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.fertnstert.2018.10.011","article-title":"Higher luteinizing hormone levels associated with antimullerian hormone in postmenarchal daughters of women with polycystic ovary syndrome","volume":"111","author":"Crisosto","year":"2019","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ecl.2020.10.003_bib26","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1210\/jc.2015-3926","article-title":"Evidence for increased 5alpha-reductase activity during early childhood in daughters of women with polycystic ovary syndrome","volume":"101","author":"Torchen","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2020.10.003_bib27","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.fertnstert.2012.08.025","article-title":"Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome","volume":"98","author":"Trottier","year":"2012","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.ecl.2020.10.003_bib28","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1210\/jc.2014-1474","article-title":"Persistent apparent pancreatic beta-cell defects in premenarchal PCOS relatives","volume":"99","author":"Torchen","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2020.10.003_bib29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1210\/jc.2016-2707","article-title":"Normal pubertal development in daughters of women with PCOS: a controlled study","volume":"102","author":"Legro","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2020.10.003_bib30","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1210\/jc.2018-02313","article-title":"Distinctive reproductive phenotypes in peripubertal girls at risk for polycystic ovary syndrome","volume":"104","author":"Torchen","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2020.10.003_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-11-0223","article-title":"Premature adrenarche: novel lessons from early onset androgen excess","volume":"165","author":"Idkowiak","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2020.10.003_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/EJE-18-0854","article-title":"Causes, patterns and severity of androgen excess in 487 consecutively recruited pre- and post-pubertal children","volume":"180","author":"Idkowiak","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2020.10.003_bib33","first-page":"1599","article-title":"Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism","volume":"76","author":"Ibanez","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2020.10.003_bib34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0015-0282(97)81396-9","article-title":"Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: evidence from gonadotropin-releasing hormone agonist testing","volume":"67","author":"Ibanez","year":"1997","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.ecl.2020.10.003_bib35","first-page":"2283","article-title":"Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche","volume":"82","author":"Ibanez","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2020.10.003_bib36","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s001250051030","article-title":"Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche","volume":"41","author":"Ibanez","year":"1998","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.ecl.2020.10.003_bib37","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","article-title":"Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth","volume":"83","author":"Ibanez","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2020.10.003_bib38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2265.2000.01133.x","article-title":"Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche","volume":"53","author":"Ibanez","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ecl.2020.10.003_bib39","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1365-2265.2003.01728.x","article-title":"Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche","volume":"58","author":"Ibanez","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.ecl.2020.10.003_bib40","first-page":"2691","article-title":"Anovulation after precocious pubarche: early markers and time course in adolescence","volume":"84","author":"Ibanez","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2020.10.003_bib41","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/humrep\/der291","article-title":"Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test","volume":"26","author":"Rosenfield","year":"2011","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.ecl.2020.10.003_bib42","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O'Reilly","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2020.10.003_bib43","first-page":"4589","article-title":"11-Ketotestosterone is the dominant circulating bioactive androgen during normal and premature adrenarche","volume":"103","author":"Rege","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2020.10.003_bib44","first-page":"2037","article-title":"The roles of insulin sensitivity, insulin-like growth factor I (IGF-I), and IGF-binding protein-1 and -3 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche","volume":"84","author":"Vuguin","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2020.10.003_bib45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1210\/jcem.87.1.8143","article-title":"Elevated free IGF-I levels in prepubertal Hispanic girls with premature adrenarche: relationship with hyperandrogenism and insulin sensitivity","volume":"87","author":"Silfen","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2020.10.003_bib46","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1210\/jc.2003-030617","article-title":"Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents","volume":"88","author":"Silfen","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2020.10.003_bib47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1442-200x.2004.02006.x","article-title":"Is premature adrenarche a risk factor for atherogenesis?","volume":"47","author":"Guven","year":"2005","journal-title":"Pediatr Int"},{"issue":"11","key":"10.1016\/j.ecl.2020.10.003_bib48","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1210\/jc.2006-2412","article-title":"Childhood metabolic syndrome and its components in premature adrenarche","volume":"92","author":"Utriainen","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2020.10.003_bib49","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1210\/jc.2006-0336","article-title":"Metformin treatment to prevent early puberty in girls with precocious pubarche","volume":"91","author":"Ibanez","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2020.10.003_bib50","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1210\/jc.2008-0013","article-title":"Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche","volume":"93","author":"Ibanez","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2020.10.003_bib51","doi-asserted-by":"crossref","first-page":"E1262","DOI":"10.1210\/jc.2011-0555","article-title":"Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence","volume":"96","author":"Ibanez","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2020.10.003_bib52","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0034-1371092","article-title":"Childhood obesity and its impact on the development of adolescent PCOS","volume":"32","author":"Anderson","year":"2014","journal-title":"Semin Reprod Med"},{"issue":"6","key":"10.1016\/j.ecl.2020.10.003_bib53","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.ecl.2020.10.003_bib54","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.fertnstert.2016.07.1121","article-title":"Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ecl.2020.10.003_bib55","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.fertnstert.2013.04.001","article-title":"Prevalence of polycystic ovary syndrome in adolescents","volume":"100","author":"Christensen","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2020.10.003_bib56","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1038\/ncomms9464","article-title":"Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome","volume":"6","author":"Day","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ecl.2020.10.003_bib57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/humrep\/dey343","article-title":"Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome","volume":"34","author":"Brower","year":"2019","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.ecl.2020.10.003_bib58","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1210\/jc.2005-0438","article-title":"Androgens before and after weight loss in obese children","volume":"90","author":"Reinehr","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2020.10.003_bib59","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/jc.2006-2002","article-title":"Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls","volume":"92","author":"McCartney","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2020.10.003_bib60","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/oby.2010.58","article-title":"Hyperandrogenemia in obese peripubertal girls: correlates and potential etiological determinants","volume":"18","author":"Knudsen","year":"2010","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"10.1016\/j.ecl.2020.10.003_bib61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.6065\/apem.2016.21.4.219","article-title":"The impact of obesity on hyperandrogenemia in Korean girls","volume":"21","author":"Kang","year":"2016","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2020.10.003_bib62","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1210\/jc.2018-02747","article-title":"Sex differences in effects of obesity on reproductive hormones and glucose metabolism in early puberty","volume":"104","author":"Nokoff","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2020.10.003_bib63","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1210\/js.2017-00013","article-title":"Increased adrenal androgens in overweight peripubertal girls","volume":"1","author":"Burt Solorzano","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"issue":"9","key":"10.1016\/j.ecl.2020.10.003_bib64","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/oby.21935","article-title":"Reduced prenatal weight gain and\/or augmented postnatal weight gain precedes polycystic ovary syndrome in adolescent girls","volume":"25","author":"de Zegher","year":"2017","journal-title":"Obesity (Silver Spring)"},{"issue":"12","key":"10.1016\/j.ecl.2020.10.003_bib65","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.tem.2018.09.005","article-title":"Central obesity, faster maturation, and 'PCOS' in girls","volume":"29","author":"de Zegher","year":"2018","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2020.10.003_bib66","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1210\/jc.2008-1252","article-title":"Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls","volume":"94","author":"McCartney","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2020.10.003_bib67","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1210\/jc.2008-1655","article-title":"Blunted sleep-related luteinizing hormone rise in healthy premenarcheal pubertal girls with elevated body mass index","volume":"94","author":"Bordini","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2020.10.003_bib68","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1210\/jc.2012-4136","article-title":"Comparison of detection of normal puberty in girls by a hormonal sleep test and a gonadotropin-releasing hormone agonist test","volume":"98","author":"Rosenfield","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2020.10.003_bib69","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1210\/jc.2013-3258","article-title":"Blunted day-night changes in luteinizing hormone pulse frequency in girls with obesity: the potential role of hyperandrogenemia","volume":"99","author":"Collins","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2020.10.003_bib70","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/jc.2018-00131","article-title":"Insulin resistance, hyperinsulinemia, and LH: relative roles in peripubertal obesity-associated hyperandrogenemia","volume":"103","author":"Burt Solorzano","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2020.10.003_bib71","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jadohealth.2016.10.015","article-title":"Anti-mullerian hormone in obese adolescent girls with polycystic ovary syndrome","volume":"60","author":"Kim","year":"2017","journal-title":"J\u00a0Adolesc Health"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852920300803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852920300803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:45:46Z","timestamp":1760175946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852920300803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0889852920300803"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2020.10.003","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic Ovary Syndrome","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2020.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}